InMed Pharmaceuticals (INM) Cash & Equivalents (2020 - 2026)
InMed Pharmaceuticals (INM) posted quarterly Cash & Equivalents of $5.2 million for Q1 2026, up 10.64% year-over-year from $4.7 million in Q1 2025, and down 25.71% quarter-over-quarter from $7.0 million in Q4 2025.
InMed Pharmaceuticals (INM) Cash & Equivalents (2020 - 2026) Analysis & Trends
InMed Pharmaceuticals' Cash & Equivalents history runs 7 years deep, the most recent figure standing at $5.2 million for Q1 2026.
- In Q1 2026, Cash & Equivalents rose 10.64% year-over-year to $5.2 million; the TTM figure through Mar 2026 stood at $5.2 million (up 10.64% YoY), while the FY2025 annual figure was $10.7 million, up 63.48% from the prior year.
- Cash & Equivalents for Q1 2026 stood at $5.2 million, down from $7.0 million in the prior quarter.
- The five-year high for Cash & Equivalents was $11.5 million in Q4 2022, with the low at $1.2 million in Q3 2024.
- The 5-year median for Cash & Equivalents is $6.6 million (2024), against an average of $6.8 million.
- The sharpest annual moves came in 2023 and 2025: Cash & Equivalents tumbled 88.58% in 2023, then jumped 654.43% in 2025.
- InMed Pharmaceuticals' Cash & Equivalents stood at $11.5 million in 2022, then sank by 88.58% to $1.3 million in 2023, then surged by 232.28% to $4.3 million in 2024, then surged by 61.06% to $7.0 million in 2025, then retreated by 25.71% to $5.2 million in 2026.
- Business Quant data shows INM's Cash & Equivalents at $5.2 million in Q1 2026, $7.0 million in Q4 2025, and $9.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | 1.11 Bn |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.33 Bn | 2.15 Bn | 3.66 Bn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 1.48 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 2.89 Bn |
| 5 | United Therapeutics | 22.15 Bn | 19.48 Bn | 683.80 Mn | 1.80 Bn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 886.50 Mn |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn | 332.40 Mn |
| 8 | Elanco Animal Health | 11.74 Bn | 11.21 Bn | 798.00 Mn | 530.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | 164.00 Mn |
| 10 | InMed Pharmaceuticals | 6.38 Mn | 1.14 Mn | - | 5.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.20 Mn |
| Dec 31, 2025 | 7.00 Mn |
| Sep 30, 2025 | 9.33 Mn |
| Jun 30, 2025 | 10.74 Mn |
| Mar 31, 2025 | 4.70 Mn |
| Dec 31, 2024 | 4.35 Mn |
| Sep 30, 2024 | 1.24 Mn |
| Jun 30, 2024 | 6.57 Mn |
| Mar 31, 2024 | 6.58 Mn |
| Dec 31, 2023 | 1.31 Mn |
| Sep 30, 2023 | 6.74 Mn |
| Jun 30, 2023 | 8.91 Mn |
| Mar 31, 2023 | 9.60 Mn |
| Dec 31, 2022 | 11.45 Mn |
| Sep 30, 2022 | 9.35 Mn |
| Jun 30, 2022 | 6.18 Mn |
| Mar 31, 2022 | 5.90 Mn |
| Dec 31, 2021 | 11.30 Mn |
| Sep 30, 2021 | 15.30 Mn |
| Jun 30, 2021 | 7.36 Mn |